This website requires JavaScript.
Latest Story

Accenture acquires Revolutionary Security

Apr 8, 2020 by The Passage Team
Accenture acquires Revolutionary Security

Accenture (NYSE: ACN) has acquired Revolutionary Security, a privately held company specializing in enterprise cybersecurity for information technology (IT) and operational technology (OT) environments. Financial terms were not disclosed.

Revolutionary Security’s portfolio of cybersecurity services includes assessment and testing, design and build of security programs and functions as well as security operations across its clients’ IT and OT systems. Revolutionary Security leverages proprietary technology and methods to help mature the security capabilities of its clients and manage risk. The company’s breach and attack simulation testing service, LiveFire®, utilizes real-world cyber threats to identify gaps in security processes and monitoring, as well as staff operations and technologies. The results help organizations prioritize actions to mitigate cyber risks within their enterprise.

Headquartered in the greater Philadelphia area, Revolutionary Security employs 90 highly skilled cybersecurity professionals throughout the United States. The company, founded in 2016, serves a variety of clients in the energy, manufacturing, healthcare, financial services and communications industries.

“The acquisition of Revolutionary Security is another demonstration of our continued commitment to invest in areas to keep our clients safe from cyber threats,” said Kelly Bissell, who leads Accenture Security globally. “Revolutionary Security’s service offerings are a perfect complement to Accenture’s portfolio, and the acquisition furthers our mission of helping clients better protect and defend their organizations across their entire ecosystem.”

The Passage Team

The Passage is committed to creating in-depth content over technology industry across Asia with a focus on emerging startups in the technology, healthcare, education, food, tech, travel & mobility segments.

Follow The Passage Team